Arrowhead Research
ARWR
256 hedge funds and large institutions have $1.85B invested in Arrowhead Research in 2023 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 83 increasing their positions, 93 reducing their positions, and 54 closing their positions.
41% more call options, than puts
Call options by funds: $10.1M | Put options by funds: $7.17M
1.7% less ownership
Funds ownership: 69.11% → 67.4% (-1.7%)
9% less funds holding
Funds holding: 282 → 256 (-26)
11% less repeat investments, than reductions
Existing positions increased: 83 | Existing positions reduced: 93
38% less capital invested
Capital invested by funds: $2.97B → $1.85B (-$1.11B)
41% less first-time investments, than exits
New positions opened: 32 | Existing positions closed: 54
50% less funds holding in top 10
Funds holding in top 10: 8 → 4 (-4)
Top Buyers
Top Sellers
ARWR Hedge Fund Activity: Q1 2023 in Review
256 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Arrowhead Research (ARWR) for Q1 2023, worth a combined $1.85B — down 38% from $2.97B a quarter earlier.
Sellers outnumbered buyers: 54 funds closed out of ARWR and 32 opened new positions — a net loss of 22 holders — while 93 trimmed existing stakes and 83 added.
The largest buyer was Rokos Capital Management (UK), adding an estimated $40.1M. The largest seller was AllianceBernstein, cutting an estimated $71.8M.
- 256 institutional investors held Arrowhead Research (ARWR) as of Q1 2023, down from 282 in Q4 2022.
- Funds reported $1.85B of Arrowhead Research stock for Q1 2023, down 38% quarter-over-quarter.
- 32 funds opened new Arrowhead Research positions in Q1 2023 and 54 closed out, a net change of -22 holders.
- The largest Arrowhead Research buyer in Q1 2023 was Rokos Capital Management (UK), an estimated $40.1M added.
- The largest Arrowhead Research seller in Q1 2023 was AllianceBernstein, an estimated $71.8M sold.
Based on aggregated 13F filings for Q1 2023.